Strategic Financial Concepts’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$699K Buy
582
+2
+0.3% +$2.04K 0.21% 101
2026
Q1
$533K Buy
+580
New +$588K 0.13% 155
2025
Q4
– Sell
-1,062
Closed -$810K – 215
2025
Q3
$810K Sell
1,062
-264
-20% -$196K 0.12% 95
2025
Q2
$1.03M Buy
1,326
+388
+41% +$302K 0.15% 83
2025
Q1
$774K Buy
938
+39
+4% +$32.5K 0.15% 144
2024
Q4
$694K Buy
899
+363
+68% +$301K 0.13% 155
2024
Q3
$475K Buy
536
+506
+1,687% +$455K 0.15% 128
2024
Q2
$26.9K Sell
30
-578
-95% -$462K 0.02% 302
2024
Q1
$473K Buy
+608
New +$433K 0.11% 166
2023
Q4
– Sell
-451
Closed -$242K – 210
2023
Q3
$242K Sell
451
-167
-27% -$86.1K 0.08% 217
2023
Q2
$290K Buy
618
+25
+4% +$10.5K 0.11% 178
2023
Q1
$204K Buy
+593
New +$200K 0.08% 220

Other funds holding LLY

Strategic Financial Concepts's LLY Position: Q2 2026 in Review

Strategic Financial Concepts increased its Eli Lilly (LLY) stake by 0.34% in Q2 2026, buying an estimated $2.04K and bringing the position to 582 shares worth $699K. The position accounts for 0.21% of the portfolio, ranked #101.

Strategic Financial Concepts first reported a position in LLY in Q1 2023 and has held it in 12 quarters since. The position peaked at $1.03M in Q2 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Strategic Financial Concepts held 582 shares of Eli Lilly worth $699K as of Q2 2026.
  • Strategic Financial Concepts bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.21% of Strategic Financial Concepts's portfolio in Q2 2026, its #101 holding.
  • Strategic Financial Concepts first reported a position in Eli Lilly in Q1 2023 and has held it in 12 quarters since.
  • Strategic Financial Concepts's Eli Lilly position peaked at $1.03M in Q2 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Strategic Financial Concepts's 13F filing for Q2 2026, filed 28 Jul 2026.